HOME > TOP STORIES
TOP STORIES
-
REGULATORY LDP to Launch Lawmakers’ League on Medical Adhesive Patches
October 27, 2022
-
REGULATORY Pfizer Assesses Cancer Risk from Amoxan as “Acceptable” at “1 in 200,000 People”
October 26, 2022
-
REGULATORY Commodity Prices Are Rising, That’s Why Full Drug Re-Pricing Needed in 2023: MOF Official
October 25, 2022
-
REGULATORY Moderna’s BA.4/5 COVID Jab Up for PAFSC Review on Oct. 31
October 25, 2022
-
BUSINESS Genmab to Branch Out into 2nd Disease Area beyond Cancer, Specifics to Be Unveiled Next Year: CEO
October 24, 2022
-
ORGANIZATION Over 80% of Wholesaler Reps Say Shipment Adjustments Take Up Most of Their Time: Survey
October 21, 2022
-
REGULATORY With Shortened Interval, Omicron Booster Likely to Cover 18 Million More People by Month-End
October 21, 2022
-
BUSINESS Kyowa Kirin Assigns Bone Metabolism Specialists to Promote Crysvita in Japan
October 20, 2022
-
BUSINESS Sumitomo Aiming to Take the Lead in Developing Universal Flu Vaccines
October 19, 2022
-
BUSINESS Bayer to Distribute Xarelto Tablets 2.5 mg via Single Wholesaler
October 18, 2022
-
REGULATORY Health Ministry Research Team to Vet Recall Rules to Address Supply Disruptions
October 17, 2022
-
BUSINESS Fujifilm Ditches Avigan COVID-19 Program, Pulls Submission in Japan
October 17, 2022
-
BUSINESS Fertility Drugs Face Supply Woes as Demand Spikes on Health Coverage
October 14, 2022
-
REGULATORY Govt Eyes Designation of Cefazolin, Other Antibiotics as Key Resources
October 14, 2022
-
REGULATORY MHLW Expert Panel Sorts Out Discussion Points for Full Debate; Focus on Innovation, Stable Supply, and Margins
October 13, 2022
-
ACADEMIA Japan Expert Sees Lecanemab Initially Treating Only a Few Tens of Thousands of Patients with Immature Care Setup
October 12, 2022
-
BUSINESS Kyushu Univ. Spinoff Aims to File NK-Like Cells in 2025, Eyes Combo with Checkpoint Drugs
October 11, 2022
-
REGULATORY Japan to Roll Out BA.4/5 Omicron Boosters on Oct. 13, Inoculations for 6 Months to 4 Years from Oct. 24
October 11, 2022
-
REGULATORY MHLW Panel to Discuss Shortening of COVID Booster Interval
October 11, 2022
-
ORGANIZATION EFPIA Chief Prods Japan on Mutual Trial Data Recognition, Cooperation to Boost Attractiveness to Rival US, China
October 7, 2022
ページ
The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…
